Oxford BioDynamics has announced the appointment of professor Iain McInnes to its scientific advisory board.
The company says that Iain will apply his expertise and insight as the EpiSwitch technology continues to be adopted by leading pharmaceutical and biotechnology companies.
Iain is currently the director of the Institute of Infection, Immunity, and Inflammation, Muirhead professor of medicine and professor of rheumatology at the University of Glasgow. He is also the president of the European League against Rheumatism (EULAR).
Christian Hoyer Millar, chief executive officer of Oxford BioDynamics, said that the company is "delighted to announce the appointment of Professor Iain McInnes and to welcome him to the OBD team. Iain is an eminent professor and an expert in inflammatory disease processes, a core focus for us. His knowledge and experience will be hugely beneficial, as we further collaborate with leading pharma, biotech and research institutions.”